Literature DB >> 23079758

Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010.

Tarak K Trivedi1, Traci DeSalvo, Lore Lee, Aimee Palumbo, Maria Moll, Aaron Curns, Aron J Hall, Manish Patel, Umesh D Parashar, Benjamin A Lopman.   

Abstract

CONTEXT: Norovirus outbreaks are common among vulnerable, elderly populations in US nursing homes.
OBJECTIVES: To assess whether all-cause hospitalization and mortality rates are increased during norovirus outbreak vs nonoutbreak periods in nursing homes, and to identify factors associated with increased risk. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study of Medicare-certified nursing homes in Oregon, Wisconsin, and Pennsylvania that reported at least 1 confirmed or suspected norovirus outbreak to the Centers for Disease Control and Prevention's National Outbreak Reporting System (NORS), January 2009 to December 2010. Deaths and hospitalizations occurring among residents of these nursing homes were identified through the Medicare Minimum Data Set (MDS). MAIN OUTCOME MEASURES: Rates of all-cause hospitalization and mortality during outbreak compared with nonoutbreak periods were estimated using a random-effects Poisson regression model controlling for background seasonality in both outcomes.
RESULTS: The cohort consisted of 308 nursing homes that reported 407 norovirus outbreaks to NORS. Per MDS, 67 730 hospitalizations and 26 055 deaths occurred in these homes during the 2-year study. Hospitalization rates were 124.0 (95% CI, 119.4-129.1) vs 109.5 (95% CI, 108.6-110.3) hospitalizations per nursing home−year during outbreak vs nonoutbreak periods, yielding a seasonally adjusted rate ratio (RR) of 1.09 (95% CI, 1.05-1.14). Similarly, mortality rates were 53.7 (95% CI, 50.6-57.0) vs 41.9 (95% CI, 41.4-42.4) deaths per nursing home−year in outbreak vs nonoutbreak periods (seasonally adjusted RR, 1.11; 95% CI, 1.05-1.18). The increases in hospitalizations and mortality were concentrated in the first 2 weeks (week 0 and 1) and the initial week (week 0) of the outbreak, respectively. Homes with lower daily registered nurse (RN) hours per resident (<0.75) had increased mortality rates during norovirus outbreaks compared with baseline (RR, 1.26; 95% CI, 1.14-1.40), while no increased risk (RR, 1.03; 95% CI, 0.96-1.12) was observed in homes with higher daily RN hours per resident (P = .007 by likelihood ratio test); the increase in hospitalization rates did not show a similar pattern.
CONCLUSION: Norovirus outbreaks were associated with significant concurrent increases in all-cause hospitalization and mortality in nursing homes.

Entities:  

Mesh:

Year:  2012        PMID: 23079758     DOI: 10.1001/jama.2012.14023

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  35 in total

Review 1.  Burden of norovirus in healthcare facilities and strategies for outbreak control.

Authors:  A Kambhampati; M Koopmans; B A Lopman
Journal:  J Hosp Infect       Date:  2015-02-04       Impact factor: 3.926

2.  Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.

Authors:  Sue E Crawford; Nadim Ajami; Tracy Dewese Parker; Noritoshi Kitamoto; Katsuro Natori; Naokazu Takeda; Tomoyuki Tanaka; Baijun Kou; Robert L Atmar; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

3.  Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples.

Authors:  Jennifer D Rogers; Nadim J Ajami; Bartlomiej G Fryszczyn; Mary K Estes; Robert L Atmar; Timothy Palzkill
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

4.  RNA populations in immunocompromised patients as reservoirs for novel norovirus variants.

Authors:  Everardo Vega; Eric Donaldson; Jeremy Huynh; Leslie Barclay; Ben Lopman; Ralph Baric; Luke F Chen; Jan Vinjé
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 5.  Norovirus immunology: Of mice and mechanisms.

Authors:  Kira L Newman; Juan S Leon
Journal:  Eur J Immunol       Date:  2015-08-25       Impact factor: 5.532

Review 6.  Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Authors:  Negar Aliabadi; Ben A Lopman; Umesh D Parashar; Aron J Hall
Journal:  Expert Rev Vaccines       Date:  2015-07-29       Impact factor: 5.217

7.  The Norovirus Epidemiologic Triad: Predictors of Severe Outcomes in US Norovirus Outbreaks, 2009-2016.

Authors:  Rachel M Burke; Minesh P Shah; Mary E Wikswo; Leslie Barclay; Anita Kambhampati; Zachary Marsh; Jennifer L Cannon; Umesh D Parashar; Jan Vinjé; Aron J Hall
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

8.  Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.

Authors:  Lisa C Lindesmith; Eric F Donaldson; Martina Beltramello; Stefania Pintus; Davide Corti; Jesica Swanstrom; Kari Debbink; Taylor A Jones; Antonio Lanzavecchia; Ralph S Baric
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

9.  Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model.

Authors:  Joana Rocha-Pereira; Abimbola O Kolawole; Eric Verbeken; Christiane E Wobus; Johan Neyts
Journal:  Antiviral Res       Date:  2016-05-29       Impact factor: 5.970

Review 10.  The burden of norovirus gastroenteritis: an important foodborne and healthcare-related infection.

Authors:  G Belliot; B A Lopman; K Ambert-Balay; P Pothier
Journal:  Clin Microbiol Infect       Date:  2014-08       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.